Work

Supplementary Tables 1 through 4 from A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Table S1. Patient disposition Supplemental Table S2. M30 and M65 for cohorts with greatest number of patients Supplemental Table S3. m65 fragment for cohort 1-3 Supplemental Table S4. caspase measurements

DOI: 10.1158/1535-7163.22506456

Authors: Ravi K. Amaravadi, Russell J. Schilder, Lainie P. Martin, Myron Levin, Martin A. Graham, David E. Weng, Alex A. Adjei

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362548000

Cites:

Cited by:

Related to: 10